By Targeting Neurotransmitter Treatment For Gastrointestinal Conditions May Be Improved

Monday, Jul. 1st 2013 7:00 AM

Selective targeting of the neurotransmitter that differentially affects brain cells that control the two distinct functions of the pancreas may allow for new medication therapies for conditions like diabetes, dyspepsia and gastro-esophageal reflux, according to Penn State College of Medicine researchers.

According to R Alberto Travagli, professor, Department of Neural and Behavioral Sciences, and lead investigator, the  study differs from what’s been reported previously about brain neurons that control the gastrointestinal tract. It provides further support to the idea that separate nerve pathways regulate the diverse functions of organs along the upper gastrointestinal tract.

VN:F [1.9.22_1171]
Rating: 0.0/5 (0 votes cast)
VN:F [1.9.22_1171]
Rating: 0 (from 0 votes)
Posted on Monday, Jul. 1st 2013 7:00 AM | by Share of Cost | in Share of Cost | No Comments »

Leave a Reply

You must be logged in to post a comment.